Safety and Efficacy of Changing to DuoTrav From Prior Therapy
NCT01230736
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
105
Enrollment
INDUSTRY
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
Travoprost 0.004%/Timolol 0.5% Fixed Combination eye drops solution (Duotrav®)
Sponsor
Alcon Research